TAK-573, an Anti-CD38/Attenuated Ifna Fusion Protein, Has Clinical Activity and Modulates the Ifna Receptor (IFNAR) Pathway in Patients with Relapsed/Refractory Multiple Myeloma
TAK-573
Below is an instruction that describes a task, paired with an input that provides further context. Write a response that appropriately completes the request. ### Instruction: Identify all the mentioned drugs in the given text. Text may or may not contain drug. If they contain more than 1 drug, use ";" as delimiter and join them. ### Input: TAK-573, an Anti-CD38/Attenuated Ifna Fusion Protein, Has Clinical Activity and Modulates the Ifna Receptor (IFNAR) Pathway in Patients with Relapsed/Refractory Multiple Myeloma ### Output: TAK-573